Covered recipient · General Payments record
KATHERINE MARIE MOCZULSKI
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$568.37
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $199.04 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| IRONSHORE PHARMACEUTICALS INC. | $65.95 | 3 |
| Acerta Pharma LLC | $41.87 | 2 |
| Amgen Inc. | $32.33 | 2 |
| ABBVIE INC. | $25.42 | 1 |
| GlaxoSmithKline, LLC. | $19.70 | 1 |
| Lilly USA, LLC | $13.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.42 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107676161 | CMS |
| Amgen Inc. | $16.28 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117631835 | CMS |
| Amgen Inc. | $16.05 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117631837 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.68 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104632767 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.19 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105719082 | CMS |
| GlaxoSmithKline, LLC. | $19.70 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116686415 | CMS |
| IRONSHORE PHARMACEUTICALS INC. | $20.29 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146241325 | CMS |
| IRONSHORE PHARMACEUTICALS INC. | $19.72 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146324349 | CMS |
| IRONSHORE PHARMACEUTICALS INC. | $25.94 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146300440 | CMS |
| Lilly USA, LLC | $13.77 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135764291 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.